US HB5444 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on December 17 2019 - 25% progression, died in committee
Action: 2019-12-18 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 17 2019 - 25% progression, died in committee
Action: 2019-12-18 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Biologics Price Competition and Innovation Act of 2009 to streamline the transition of certain products from approval as a drug to licensure as a biological product, and for other purposes.
Title
Lower Insulin Costs Now Act
Sponsors
| Rep. Lauren Underwood [D-IL] | Rep. Janice Schakowsky [D-IL] | Rep. Brett Guthrie [R-KY] | Rep. Mike Kelly [R-PA] |
| Rep. Andy Levin [D-MI] | Rep. Brian Fitzpatrick [R-PA] | Rep. Scott Perry [R-PA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-12-18 | House | Referred to the Subcommittee on Health. |
| 2019-12-17 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-12-17 | House | Introduced in House |
Same As/Similar To
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
SB2103 (Related) 2019-07-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
HB6155 (Related) 2020-03-09 - Referred to the House Committee on Energy and Commerce.
HB1865 (Related) 2019-12-20 - Became Public Law No: 116-94. (TXT | PDF)
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
SB2103 (Related) 2019-07-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
HB6155 (Related) 2020-03-09 - Referred to the House Committee on Energy and Commerce.
HB1865 (Related) 2019-12-20 - Became Public Law No: 116-94. (TXT | PDF)
Subjects
Biological and life sciences
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Intellectual property
Licensing and registrations
Prescription drugs
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Intellectual property
Licensing and registrations
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/5444/all-info |
| Text | https://www.congress.gov/116/bills/hr5444/BILLS-116hr5444ih.pdf |
